0001213900-23-010983.txt : 20230213 0001213900-23-010983.hdr.sgml : 20230213 20230213213931 ACCESSION NUMBER: 0001213900-23-010983 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230209 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAGLIAFERRI MARY CENTRAL INDEX KEY: 0001323304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 23621599 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2023-02-09 0 0000316253 ENZO BIOCHEM INC ENZ 0001323304 TAGLIAFERRI MARY C/O ENZO BIOCHEM, INC. 81 EXECUTIVE BLVD. SUITE 3 FARMINGDALE NY 11735 1 0 0 0 Common Stock, $0.01 Par Value 2023-02-09 4 A 0 75188 0 A 155917 D The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., February 9, 2024), or (ii) a change of control event. /s/ Mary Tagliaferri 2023-02-13